Compare ACON & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACON | DLXY |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | Singapore |
| Employees | 11 | 11 |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 7.2M |
| IPO Year | N/A | N/A |
| Metric | ACON | DLXY |
|---|---|---|
| Price | $2.42 | $0.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 34.2K | ★ 132.5K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $87.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.34 | $0.34 |
| 52 Week High | $12.03 | $7.00 |
| Indicator | ACON | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 27.51 | 47.89 |
| Support Level | $2.38 | $0.44 |
| Resistance Level | $3.54 | $0.55 |
| Average True Range (ATR) | 0.15 | 0.04 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 8.54 | 35.09 |
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Delixy Holdings Ltd a holding company. Through its subsidiary, it is principally engaged in the trading of oil-related products, which are broadly categorized into crude oil and oil-based products, including naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. These products are traded across multiple countries in Southeast Asia, East Asia, and the Middle East, and the Group has established a presence in the oil trading markets in these countries. The majority of the Group's revenue is generated from the trading of crude oil. Geographically, it derives maximum revenue from its business in East Asia.